Neurovascular Embolization Devices Market Growing At 4%

(Persistence Market Research)

As per Persistence Market Research, the global neurovascular embolization devices market is expected to account for more than $1,733.1 Million by 2028 end. The company’s report projects significant growth potential with average year-on-year growth rate estimated at 4.4% through 2028. Market growth is attributed to increasing demand for minimally invasive neurosurgical procedure for better patient outcomes. Additionally, the increasing awareness regarding neurovascular disease, and technological advancements in the diagnostic techniques are expected to propel the demand for neurovascular embolization devices over the forecast period.

 

Sponsored by Infosys

In Conversation with Antonio Neri, President & CEO – Hewlett Packard Enterprise & Salil Parekh, CEO – Infosys

Hear the CEOs of Infosys & HPE discuss the current crisis and how it has accelerated the need for digital transformation for their clients. Connectivity at the Edge, right mix of hybrid cloud, ability to extract data faster than ever before… these are just some of the contributions that HPE and Infosys make to our clients’ digital transformation journey.

 Highlights

  • It is claimed by the Brain Aneurysm Foundation that around 6 million people in the U.S. suffer from brain aneurysms, which is expected to fuel the adoption minimally invasive neurovascular procedure. This factor further increases the demand for neurovascular embolization devices from the individuals suffering from cerebral aneurysms.
  • Outpatient centers segment is projected to grow at a CAGR of 4.8% over the forecast period due to increasing demand for minimally invasive surgeries.
  • North America is projected to be the dominant regional market for neurovascular embolization devices over the forecast period.
  • Asia Pacific neurovascular embolization devices market is projected to grow at a CAGR of 5.2% due to growing awareness regarding brain aneurysms and other neurovascular diseases as well as significant presence of key manufacturers.
  • In terms of revenue, the embolization devices product type segment of the neurovascular embolization devices market is expected to hold significant share and grow at a high CAGR of 4.9% in the global neurovascular embolization devices market over the forecast period.
  • Flow diversion stents segment in the neurovascular embolization devices market is also expected to grow at a significant CAGR owing to the low associated risks and their growing adoption by the end users.
  • Aneurysm clips segment in the neurovascular embolization devices market is estimated to contribute 2.4% market share in the terms of revenue.
  • The hospital end-use segment in the neurovascular embolization devices market is predicted to exhibit growth by 4.2% CAGR during the forecast period.
  • Outpatient centers hold key growth opportunity due to emergence of minimally invasive treatment modalities such as embolization coils, liquid embolic systems. North America neurovascular embolization devices market is estimated to create an incremental opportunity of $229.7 Million between 2018 and 2028.

To learn even more findings, request a sample report.

Suggested Articles

Earlier reports indicated AMD may buy Xilinx for $30 billion, but Xilinx refused to discuss the matter at its Wednesday conference call

AI inference performance metrics matter but most companies are still looking for the financial payoff

Revenues overall hit $3.82 billion, up 1% from third quarter of 2019, as auto plants reopened and personal electronics revenues grew